Health and Early Life Microbiota
- Conditions
- AllergyNoncommunicable DiseasesChild DevelopmentGrowthOverweightInfectious Disease
- Registration Number
- NCT03996304
- Lead Sponsor
- University of Helsinki
- Brief Summary
The aim of this cohort is to identify environmental, lifestyle and genetic factors that modify the human intestinal microbiota development during the first years of life, and to identify early microbiota features that associate to child health and well-being with focus on the development of allergic diseases and overweight.
- Detailed Description
1055 healthy term infants born in 2016-2018 mainly at the capital region of Finland, and their parents. Fecal samples collected from infants and their parents. Electronic questionnaires on a weekly basis during the first 4 months of life, thereafter less frequently. Focus on diet, well-being and health and social manners. At one-year and at two-years comprehensive questionnaires including development and cognition. Parental stress evaluation included.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1055
- General population, singleton pregnancy, at least one parent Finnish speaking
- Willingness and ability of parents to consent for 2 year follow-up involving frequent electronic questionnaires and freezing of faecal samples at home
- Infant born on gestational weeks 37-42 without known congenital defects
Exclusion Criteria
- Preterm birth
- Severe birth defect
- Parents fail to activate the online questionnaires
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Longitudinal change of intestinal microbiota in early life From 3 weeks to 2 years after birth Developmental trajectory of the intestinal microbiota, assessed with 16S rRNA gene amplicon and shotgun sequencing of fecal DNA to determine the changes in the intestinal microbiota composition, diversity and functionality from week 3 to weeks 6,9,12 and months 6,9,12,18 and 24 after birth.
- Secondary Outcome Measures
Name Time Method Weight At 6,12,18 and 24 months after birth Weight in kilograms.
Number of children with asthma At 2 years Specialist/Physician-diagnosed asthma.
Number of children with allergic disease At 2 years Specialist/Physician-diagnosed wheeze, eczema/atopic dermatitis, allergic rhinitis, food allergy or atopy.
Child development At 18 and 24 months after birth By means of questionnaires and, on a randomly selected group of study subjects, developmental testing to assess cognitive, motor, socio-emotional and verbal development.
Number of respiratory tract infection episodes From birth to 2 years of age Number of physician-diagnosed respiratory track infections.
Growth At 6,12,18 and 24 months after birth Height in centimeters.
Trial Locations
- Locations (1)
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki
🇫🇮Helsinki, Finland